Literature DB >> 2565428

Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a central African country. Rwandan HIV Seroprevalence Study Group.

.   

Abstract

In December, 1986, a nationwide serological survey of human immunodeficiency virus type 1 (HIV-1) infection in the general population of Rwanda was done in two parts--one in the rural and the other in the urban population. The sampling method was a modification of the cluster sampling technique developed for monitoring immunisation coverage. Antibodies to HIV-1 (and to HIV-2 and human T-cell leukaemia/lymphoma virus type I [HTLV-I]) were detected by immunoenzymatic assays and confirmed by western blot. The number of clusters surveyed was 30 in each setting, urban and rural. HIV-1 seroprevalence was 17.8% (95% confidence interval 14.3-21.2%) in the urban sample (n = 1870) and 1.3% (0.5-2.2%) in the rural sample (n = 742). In the urban sample, females were more frequently HIV-1 seropositive than males (21.0% vs 14.6%). Age-specific peaks of HIV-1 seroprevalence were identified at 0 to 5 years of age (10.1%) and at 26-40 years (30.0%). No differences in seroprevalence were observed in terms of age and sex in the rural sample. None of the sera were seropositive for HIV-2 and HTLV-I seroprevalence was 0.2% in the urban sample and 0.3% in the rural. Nationwide serological surveys could be effective in evaluating the spread of HIV infection and the efficacy of public health interventions against AIDS in developing countries.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565428

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Current trends in Rwanda's HIV/AIDS epidemic.

Authors:  E Kayirangwa; J Hanson; L Munyakazi; A Kabeja
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

2.  A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.

Authors:  N T Constantine; M Fathi Sheba; A L Corwin; R S Danahy; J D Callahan; D M Watts
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

Review 3.  Ocular problems in AIDS.

Authors:  P Kestelyn
Journal:  Int Ophthalmol       Date:  1990-05       Impact factor: 2.031

Review 4.  Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

Authors:  C B Nourse; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

5.  HIV1 infection in extra-European students in Turin (Italy): epidemiologic pattern and risk factors.

Authors:  B Adele; Z Carla; M R Angela
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

6.  Sexual partner change and condom use among urban factory workers in northwest Tanzania.

Authors:  M W Borgdorff; L R Barongo; J N Newell; K P Senkoro; W Devillé; J P Velema; R M Gabone
Journal:  Genitourin Med       Date:  1994-12

7.  [Association of malignant tumors of the conjunctiva and HIV infection in Kinshasa (D. R. Congo). First results].

Authors:  A Timm; G Stropahl; M Schittkowski; C Sinzidi; D Kayembe; R Guthoff
Journal:  Ophthalmologe       Date:  2004-10       Impact factor: 1.059

8.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

9.  Quantifying HIV-1 transmission due to contaminated injections.

Authors:  Richard G White; S Cooper Ben; Anusha Kedhar; Kate K Orroth; Sam Biraro; Rebecca F Baggaley; Jimmy Whitworth; Eline L Korenromp; Azra Ghani; Marie-Claude Boily; Richard J Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

10.  Molecular and phylogeographic analysis of human immuno-deficiency virus type 1 strains infecting treatment-naive patients from Kigali, Rwanda.

Authors:  John Rusine; Suzanne Jurriaans; Janneke van de Wijgert; Marion Cornelissen; Brenda Kateera; Kimberly Boer; Etienne Karita; Odette Mukabayire; Menno de Jong; Pascale Ondoa
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.